NEW YORK—In this issue, our series exploring anesthesia-related litigation examines a case in which physicians involved in an endoscopy were accused of improper management of both the anesthesia and the procedure, which was performed at an ambulatory surgery center (ASC)–a setting that may be particularly vulnerable to mishaps and litigation.

“As these ASCs have proliferated, the number of cases and claims against them have skyrocketed and continue to climb,” said Michael Schoppmann, JD, the CEO of MLMIC Insurance Co.

“If you have a contract with one of these facilities, be very careful. I would recommend going there ahead of time to inspect the facility, the protocols, the equipment, and ask questions because the standards you might take for granted as normal quality of care don’t always exist here. Remember, if you work somewhere and their equipment or protocols are subpar, you inherit that responsibility.”

Schoppmann and Patricia Fogarty Mack, MD, a professor of clinical anesthesiology at Weill Cornell Medical College, in New York City, discussed the case at the 2024 annual PostGraduate Assembly in Anesthesiology.

image

The Case and Outcomes

The patient was a 69-year-old man referred to gastroenterology with pain and bloating. He had a complicated past medical history, with comorbidities including coronary artery disease with stent placement, sleep apnea, hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and end-stage renal disease (ESRD) with hemodialysis.

The initial exam showed that the patient needed an upper endoscopy. The anesthesiologist, noting the patient’s comorbidities, classified him as ASA physical status class III, and the patient signed consent for both anesthesia and the procedure. The anesthesiologist proceeded with sedation, administering an initial 50 mg of propofol, and subsequently 50 mg. The patient’s oxygen saturation fell from 99% to 85%, and the endoscopy was discontinued. The anesthesiologist placed oral and nasal airways and attempted to mask the patient. The patient’s heart rate decreased to 40 beats per minute, so the anesthesiologist administered atropine; and the patient’s heart rate increased to 70 beats per minute and blood pressure rose to 206/102 mm Hg. To treat the high blood pressure, the anesthesiologist administered labetalol. The patient’s blood pressure stabilized at 155/86 mm Hg and he was transported to recovery. There, he was stable and breathing spontaneously, but remained unresponsive.

Emergency medical services transported the patient to an emergency department. Further evaluation determined the patient had experienced a hypoxic event. He was diagnosed with anoxic brain injury with subsequent cognitive defects, and required assistance in activities of daily living until his death four years later.

The experts who reviewed the case identified the following as liability issues: lack of documentation of preoperative history and physical or preoperative vital signs, failure to obtain medical clearance to ensure the patient was optimized, and the choice of an ASC setting as the site of care for this patient with significant comorbidities. An initial demand for $10 million by the family was made of all parties; eventually the case was settled on behalf of the anesthesiologist for $2.1 million in indemnity after $147,175 in expenses was paid in defense costs.

What Could Have Been Done Better?

By stopping the procedure, placing oral and nasal airways, starting bag-valve-mask ventilation, and managing the patient’s heart rate and blood pressure, the anesthesiologist did a lot of things right when things started to go wrong. But considering the patient’s medical history, they should have insisted on ensuring the patient was optimized, especially regarding his ESRD. There did not appear to be any plan for managing his coronary stent. The number of medical conditions and the lack of documentation of recent assessment of those conditions made the patient a less than ideal candidate for care in an ASC, Mack said.

“Given the stent, end-stage renal disease and other comorbidities, how many of us would even allow this patient to be scheduled at our hospital-affiliated ASC? In my opinion, this is the crux of the matter: This patient could have had medical clearance and the blessings of every subspeciality in the world, but this is not a great case for an office-based procedure.”

Schoppmann added that the very thought of obtaining medical clearance is a sign that you need to get it.

“I know it can be difficult with scheduling, but if you’re thinking about it, if that little voice in the back of your head is asking, ‘should we get medical clearance,’ you already know the answer. The ability to defend the case will be so much stronger if someone else says, ‘I agreed with the anesthesiologist, and I cleared the patient.’”

By Monica J. Smith


Mack and Schoppmann reported no relevant financial disclosures.

Editor’s note: None of the cases explored in this series occurred at Weill Cornell Medical Center.